AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 201-220 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
201
Kurs Orbital
lowweak
Opp 2
Risk 1

Thesis: There is limited relevance support that Kurs Orbital is an operating in-orbit servicing company, which could fit a long-horizon commercial space opportunity framework, but the evidence is only undated directory-style article context rather than direct company-specific positive events or facts.

Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain.

Evidence
  • Space Index lists Kurs Orbital, HQ Turin, Italy, status 'operating' within 'In-Orbit Servicing & Assembly Companies.' This is undated supporting article context, not a dated company-specific event. spaceindex.io

Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided.

202
Leidos Holdings, Inc.
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources rationale says Leidos delivered a cloud-based Joint Management Tool to DISA for SATCOM visibility and modernization, suggesting a role in defense SATCOM infrastructure, but no within the recent evidence window evidence are available to support a stronger long-horizon opportunity thesis.

Why now: No surviving evidence are available after the 90-day filter despite 300 articles considered. The rationale cites: and: but no are provided in these reviewed sources.

Caveats: Membership rationale is not direct directional proof. No retained evidence after recent evidence window. Cohort fit is ambiguous because support is infrastructure/IT modernization rather than operator economics.

203
LeoLabs, Inc.
lowweak
Opp 2
Risk 1

Thesis: LeoLabs is described in membership rationale as deploying radar for space domain awareness with Space Force/SpaceWERX support, which is strategically relevant, but no available direct evidence support a stronger opportunity call.

Why now: No dated company-specific evidence are available after filtering, so there is no strong timing signal in these reviewed sources.

Caveats: No usable evidence after recent evidence window. Membership rationale is insufficient for a high score.

204
Leonardo S.p.A.
lowweak
Opp 2
Risk 1

Thesis: Older context suggests strategic optionality from self-funding an Earth-observation constellation of 20 radar and IR imagers, but this evidence is outside the 90-day recent evidence window and therefore insufficient for a strong current ranking.

Why now: The only concrete company-specific article summary says Leonardo was self-funding a 20-satellite Earth-observation constellation on February 23, 2026, but that date is older than the March 29, 2026 cutoff, so recency is insufficient for a stronger current thesis.

Evidence
  • February 23, 2026: Leonardo is self-funding development of an Earth observation constellation consisting of 20 radar and IR imagers. This is strategically positive context but outside the 90-day recent evidence window cutoff. spacetimespod.substack.com

Caveats: The cited article is outside the 90-day recent evidence window; reviewed sources reports kept_rows 0 and dropped_rows 2. No retained positive or negative evidence exist after filtering. Article-level recap context is weaker than direct event/fact evidence.

205
Lockheed Martin Corporation
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources membership rationale references space and defense satellite activity that could support long-term opportunity, but no usable recent evidence window-valid evidence are available here.

Why now: There is no available why-now evidence within the 90-day recent evidence window; coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites, and, but no representative articles or evidence are available in the reviewed sources body for citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects insufficient current reviewed sources evidence, not a negative fundamental view.

206
Lux Aeterna
lowweak
Opp 2
Risk 2

Thesis: The membership rationale says Lux Aeterna completed a $10 million seed financing and is building a fully reusable satellite platform, which is directionally positive, but the reviewed sources contain no retained within the recent evidence window article evidence or to support a stronger thesis.

Why now: No within the recent evidence window evidence were retained for ranking, so there is no evidence-backed near-term or durable timing edge beyond generic early-stage company progress assumptions.

Caveats: Membership rationale references article: but the reviewed sources does not include its or a retained evidence row.

207
Lynk Global, Inc.
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources say Lynk Global was listed as a payload on a Falcon 9 rideshare mission, which hints at tangible space activity and gives slightly more concrete relevance than pure market-list context, but it still does not establish a supported long-horizon opportunity thesis without direct evidence or.

Why now: If a rideshare payload mention reflects program progress, that could matter over 1 year+, but the reviewed sources provide no citable event details, timestamps, quote, or for article ids: and

Caveats: A payload mention is more concrete than generic context, but still insufficient here because no direct evidence row or citation is included. No recent evidence window-surviving evidence exists in the reviewed sources. Slight score uplift reflects somewhat more operationally concrete context only.

208
MBRYONICS Ltd
lowweak
Opp 2
Risk 2

Thesis: There is weak potential opportunity from the reviewed sources' membership rationale that MBRYONICS was a partner on an ESA optical communications project, but the ranking reviewed sources contain no kept direct evidence or citable for that claim.

Why now: Why now is weak because only a membership rationale references article about participation in an ESA optical communications project led by Kepler Communications, but no article or reviewed evidence is available for ranking citation.

Caveats: Relation-style partnership context cannot be overused as directional proof. No article is provided for article. Coverage after recent evidence window is empty.

209
Mercury Systems Inc
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources rationale says Mercury supplies solid-state data recorders for SDA tracking satellites, which supports space-program exposure, but there are no retained within the recent evidence window evidence to confirm timing, scale, or durability.

Why now: There is no surviving 90-day evidence to establish a current catalyst. The rationale references and: without in these reviewed sources.

Caveats: Supplier exposure alone is not enough for a strong positive thesis without direct, timely event evidence. No retained evidence after recent evidence window.

210
Meridian Space
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources rationale says Meridian Space is a broadband constellation for which 280 satellites are being built, which suggests strategic scale potential, but the actual article evidence is not surfaced in the reviewed sources fields used for ranking, so opportunity support is limited.

Why now: Why now is weak because there are no representative articles or available evidence after recent evidence window, and the only support is the membership rationale referencing: without article summary details in the ranking fields.

Caveats: No representative article content is included for direct citation beyond membership rationale reference. No direct positive or negative evidence are available after recent evidence window. Scoring is constrained by sparse surfaced evidence.

211
Motiv Space Systems
lowweak
Opp 2
Risk 2

Thesis: Only a weak opportunity case is supported: undated external article-context lists Motiv Space Systems as an operating in-orbit servicing and assembly company, which suggests continued relevance to the sector but does not prove current growth, contracts, or milestones.

Why now: Why now is weak because the only provided evidence is undated context from Space Index identifying Motiv as operating in in-orbit servicing; no recent dated milestone or contract is supplied.

Evidence
  • Undated Space Index context lists Motiv Space Systems in Pasadena, California as an operating in-orbit servicing and assembly company. spaceindex.io

Caveats: Evidence is undated and supporting article context only. Reviewed evidence membership rationale mentions acquisition by Rocket Lab and robotics products, but no citable evidence are included here for direct ranking use. No current source-cited catalyst was found in the reviewed sources.

212
Mynaric AG
lowweak
Opp 2
Risk 2

Thesis: Membership rationale describes Mynaric as a laser optical communications terminal provider acquired by Rocket Lab, which implies strategic relevance to space communications hardware, but no direct evidence within the recent evidence window are available to support a durable opportunity call.

Why now: No within the recent evidence window retained evidence exists. The reviewed sources references and in the membership rationale, but no or retained evidence are provided here.

Caveats: No available direct evidence survived the 90-day recent evidence window. Acquisition/status claim appears only in membership rationale here and cannot be fully evaluated for timing without or timestamps.

213
Mynaric AG
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources rationale says Mynaric is an acquired laser optical communications company, indicating potentially strategic technology relevance, but there is no direct positive evidence row, quote, or to support a durable opportunity thesis.

Why now: Potential relevance depends on the timing and implications of acquisition-related developments, yet the reviewed sources supplies no article summary, or surviving evidence row for article ids, or

Caveats: Acquisition-related statements are time-sensitive, but chronology cannot be verified from these reviewed sources because and timestamps are absent at the evidence level. No evidence remain after recent evidence window despite support references being listed. Slight score uplift reflects reviewed sources rationale about optical communications relevance only.

214
N SPACE TECH
lowweak
Opp 2
Risk 2

Thesis: N SPACE TECH has thematic relevance because the membership rationale profiles it as an Indian aerospace/defense startup designing CubeSats, RF subsystems, radars, and antennas and working with ISRO and DRDO, but the reviewed sources contain no retained 90-day evidence to convert that profile into a current opportunity thesis.

Why now: There is no retained within the recent evidence window evidence in the reviewed sources, so there is no demonstrated current catalyst despite the company profile reference.

Caveats: Only a membership rationale is present; no recent evidence are retained. Score remains low due to evidence scarcity.

215
Nanoracks
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources includes one external article summary saying NASA awarded Nanoracks a $160 million contract to develop a commercial space station, which is strategically positive if still relevant, but the article is dated September 2, 2025 and was dropped by the 90-day recent evidence window, so support for a current 1 year+ opportunity ranking is weak.

Why now: There is no valid within the recent evidence window catalyst. The only company-specific article is at with September 2, 2025, and the reviewed sources say it was excluded by the 90-day cutoff.

Evidence
  • External article summary states NASA awarded Nanoracks a $160 million contract to develop a commercial space station to help replace the ISS; is September 2, 2025, but the reviewed sources' recent evidence review says the row was dropped as outside the 90-day window. scimyst.com

Caveats: The only cited article is outside the selected 90-day evidence recent evidence window and therefore should not drive strong ranking. This is supporting source context, not merged serving evidence. No retained direct positive or negative evidence remain after recent evidence window.

216
NordSpace
lowweak
Opp 2
Risk 4

Thesis: Reviewed evidence membership rationale says NordSpace is a private Canadian aerospace/defence startup awarded defense funding for a VLEO satellite concept and planning launches from its own spaceport complex, which would be strategically relevant if current, but no direct evidence or article summaries survived the available recent evidence window in these reviewed sources, so opportunity cannot be ranked highly on evidence alone, unavailable in reviewed sources).

Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after the 90-day filter, so there is no current catalyst evidence to support a 1 year+ differentiated view from these reviewed sources.

Caveats: No article is provided for the membership-support. No direct positive or negative evidence were available after recent evidence window. Private-company status reduces external validation in these reviewed sources.

217
NorthStar Earth & Space Inc.
lowweak
Opp 2
Risk 4

Thesis: There is not enough in-window evidence in this specific row to support a strong positive thesis beyond generic cohort relevance.

Why now: Why-now is weak because the evidence recent evidence review shows zero kept rows after the 90-day cutoff and the row contains no representative articles or direct evidence, so recency and business state are uncertain in these reviewed sources.

Caveats: No evidence were available after the recent evidence window for this row. Any statement about public listing, SPAC timing, or operations would be insufficiently grounded from this row alone. Score is driven by evidence absence, not by documented adverse developments.

218
OHB SE
lowweak
Opp 2
Risk 2

Thesis: OHB may have long-horizon opportunity through satellite manufacturing and in-orbit testing infrastructure exposure, as the membership rationale says Mimir 1 was built by OHB Sweden, but there is no retained 90-day evidence in the reviewed sources to support a current ranking catalyst.

Why now: There is no within the recent evidence window retained evidence to establish a fresh catalyst or changing business state.

Caveats: Only membership rationale is available; no quoted retained evidence are included. Low score reflects weak current evidence rather than a negative fundamental view.

219
Optera
lowweak
Opp 2
Risk 2

Thesis: Phase-2 rationale says Optera received UK space-sector early-stage funding and additional private capital, which could be positive if confirmed, but the current reviewed sources retains no in-window evidence to support a stronger ranking.

Why now: There is no retained representative article or evidence row inside the current 90-day recent evidence window for Optera, so recency for the claimed funding support is uncertain in these reviewed sources.

Caveats: No retained evidence after recent evidence window. Phase-2 membership rationale is not enough for a high-conviction thesis on its own.

220
Paladin Space
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence membership rationale says Paladin Space is partnering to offer debris removal as a service using its Triton payload, which suggests exposure to on-orbit servicing and sustainability themes over a long horizon, but no citeable direct evidence are provided.

Why now: Why now is weak since the reviewed sources contain no direct post-recent evidence window evidence establishing current deal timing or mission progress.

Caveats: One-article universe with no citeable -bearing evidence available. Partnership mention in membership rationale cannot be strongly weighted without direct evidence.

Risk view

Showing rows 1-20 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
1
Blue Origin
mediummedium
Opp 6
Risk 7

Thesis: Execution risk is elevated because the same recent evidence set documents a New Glenn launchpad explosion on May 28, 2026, creating material uncertainty around launch reliability and schedule even though government customers reaffirmed support.

Why now: The setup is active and recent: on May 30, 2026 SpaceNews reported Blue Origin received an NSSL task order hours before a New Glenn explosion, while on May 27, 2026 GeekWire reported New Glenn was preparing to return to service for an Amazon Leo mission after its first launch failure; on May 26, 2026 Investing.com summarized a NASA moon-base contract with launch no earlier than fall 2026

Evidence
  • Published May 30, 2026: SpaceNews reported the task order came hours before a New Glenn launch vehicle exploded during a hot fire test at Cape Canaveral on May 28. spacenews.com
  • Published May 27, 2026: GeekWire said Blue Origin was returning New Glenn to service five weeks after its first launch failure. geekwire.com
  • Published May 30, 2026: Space Force awarded Blue Origin a National Security Space Launch Phase 3 Lane 1 task order for an NRO mission. spacenews.com

Caveats: Positive evidence is mostly supporting article context rather than direct events. One external article is undated and is not relied on for recency proof. Government support after the anomaly partially offsets, but does not erase, execution risk.

2
Katalyst Space Technologies
highstrong
Opp 8
Risk 6

Thesis: Risk is also elevated because the mission profile is technically ambitious and schedule-sensitive: the rescue concept is framed as potentially the first time a commercial robotic spacecraft docks with an unprepared government satellite, and the telescope is described as at risk of deorbit by late 2026, implying high execution stakes.

Why now: Why now is strong because the latest dated evidence on June 23, 2026 adds new capital after the May 29, 2026 NASA-related mission context, supporting a 1 year+ thesis that the company is moving from concept credibility toward funded development in on-orbit servicing.

Evidence
  • The Swift Observatory is described as at risk of uncontrolled deorbit by late 2026, and the mission would require a first-of-its-kind commercial robotic docking with an unprepared government satellite, implying substantial execution risk. katalystspace.com
  • Katalyst announced a NASA Phase III SBIR contract to develop a concept for a responsive rendezvous mission to save the Neil Gehrels Swift Observatory, with a proposed rescue mission that would raise its orbit and extend operational life. katalystspace.com
  • On June 23, 2026, Katalyst announced it raised $12 million to develop its NEXUS robotic spacecraft and expand satellite servicing across multi-orbit and multi-mission operations. pulse2.com

Caveats: Part of the positive case comes from company-issued materials and supporting article context rather than independent positive evidence. The May 29, 2026 article includes a dated source date but describes an announcement text beginning 'August 11, 2025'; chronology should therefore be read carefully, with the treated as the recency marker for this retrieved item. Citation

3
Anduril Industries
mediummedium
Opp 7
Risk 5

Thesis: Risk remains elevated because the reviewed sources' evidence is mostly supporting article context rather than company-specific positive evidence, and program participation does not confirm revenue realization, production conversion, or margin outcomes. The capital raise also implies a company still in heavy scale-up mode rather than de-risked execution.

Why now: The timing is supported by recent 2026 article context around Space Force Andromeda participation and the June 19, 2026 financing context, which together suggest active momentum over the last quarter.

Evidence
  • Published April 8, 2026: U.S. Space Force SSC awarded 14 companies more than $1.8B in firm fixed price Andromeda contracts for RG-XX satellites; the companies include Anduril Industries. defensedaily.com
  • Published June 19, 2026: Anduril Industries raised a $5B Series H round, bringing total funding to $11B. spaceambition.substack.com

Caveats: Most evidence is weak context-only article evidence, not direct positive events in the available ranking rows.

4
AST SpaceMobile, Inc.
highstrong
Opp 8
Risk 5

Thesis: Risk remains elevated because the thesis still depends on large-scale deployment and commercialization execution; the reviewed sources show authorization and partnerships, but limited direct proof of broad revenue conversion or completed network rollout inside the recent evidence window.

Why now: The key timing event is the FCC authorization dated April 21, 2026/April 22, 2026 granting authority for up to 248 satellites and direct-to-device service, a milestone that can unlock U.S. commercial and government use cases over a 1 year+ horizon. Later-dated company-site context on June 23, 2026 also says AST has nearly 60 operator partners and targets direct broadband to standard smartphones.

Evidence
  • Published April 21, 2026: FCC granted AST SpaceMobile authority to launch and operate a 248-satellite constellation and provide direct-to-cell service. satnews.com
  • Published April 22, 2026: company said FCC commercial authority enables operation of up to 248 satellites to deliver supplemental coverage from space directly to unmodified mobile devices. businesswire.com
  • Published March 3, 2026: TELUS signed a commercial agreement with AST and would invest in ground infrastructure and become an equity shareholder. businesswire.com

Caveats: Much of the evidence is company, press-release, or article-context based rather than independent hard performance metrics. The reviewed sources cites a target of 45 to 60 BlueBird satellites by end-2026 in article summary context, but this is not available as a direct structured fact here.

5
Atomic-6
lowweak
Opp 4
Risk 5

Thesis: Risk is moderate because none of the underlying article summaries or are provided in the visible evidence section, so the apparent positives cannot be independently grounded from the reviewed sources output beyond the rationale text.

Why now: The reviewed sources rationale cites article and says Atomic-6 launched an orbital data center service and has DoD and U.S. Space Force contracts, but no representative article or is provided in the visible reviewed sources, so timing confidence is limited.

Caveats: No direct evidence or article are available in the reviewed sources body. Opportunity thesis relies on membership rationale rather than citable article summary. Because the underlying evidence is not exposed, conviction must stay low.

6
Intuitive Machines, Inc.
mediummedium
Opp 6
Risk 5

Thesis: Risk is also moderate because the evidence is lighter than for top-ranked names and the key contract appears to be an IDIQ selection/competition vehicle rather than a clearly quantified standalone revenue award in the reviewed sources.

Why now: The timing case comes from May 12, 2026 reporting that Intuitive Machines was selected for the Space Force Andromeda IDIQ to develop space surveillance capabilities through 2030 and beyond, described as the company's first major selection following the Lanteris Space acquisition.

Evidence
  • Published May 12, 2026: Intuitive Machines said it was selected by the U.S. Space Force for the Andromeda IDIQ contract to develop space surveillance capabilities. investing.com
  • Published April 8, 2026: Defense Daily summarized that Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts, and the company list includes Intuitive Machines. defensedaily.com

Caveats: The reviewed sources provide supporting article context but no direct structured fact with quantified contract value specific to Intuitive Machines. No direct adverse evidence is available; risk is based on competitive award structure and evidence limitations. Long-horizon upside depends on conversion from selection status into meaningful programs.

7
Momentus
mediummedium
Opp 7
Risk 5

Thesis: Risk remains elevated because the evidence set emphasizes announcements and pipeline/contract positioning rather than broad proof of scaled recurring commercial adoption; some supportive contract context, including SHIELD selection, is older than the recent evidence window and should not be over-weighted for recency.

Why now: Why-now is supported by recent mission and contract evidence within the recent evidence window: on March 30, 2026 Momentus announced the successful launch of Vigoride 7 and called it its most advanced on-orbit demonstration campaign to date; on June 17, 2026 it announced a new commercial contract with LASP to host and operate the OWLS mission on Vigoride-9, expanding its commercial revenue portfolio.

Evidence
  • Momentus announced the successful launch of its Vigoride 7 Orbital Service Vehicle, calling it a major milestone and the start of its most advanced on-orbit demonstration campaign to date. businesswire.com
  • Momentus said it secured a new commercial contract with the University of Colorado Boulder’s LASP to host and operate the OWLS mission on the Vigoride-9 Orbital Service Vehicle, further expanding its commercial revenue portfolio. businesswire.com

Caveats: The SHIELD contract-vehicle selection is dated December 10, 2025 and outside the 90-day recent evidence window, so it is useful background but not a recency catalyst here. Some weak context rows repeat the same article-level claims and are not independent confirmation.

8
Momentus Inc
lowweak
Opp 4
Risk 5

Thesis: Momentus receives the highest risk score in the thin-evidence group because the reviewed sources references a commercial contract but provides no current available corroboration, leaving substantial uncertainty around execution, financing durability, and contract conversion. This is still an evidence-gap risk, not a confirmed adverse-event thesis, because no direct negative evidence is available (: and: unavailable in reviewed sources).

Why now: Why now is medium because an orbital services contract can matter over a 1 year+ horizon, but the reviewed sources' post-recent evidence window evidentiary absence prevents stronger timing confidence.

Caveats: No direct evidence remained after the recent evidence filter.

9
Orbex
mediumweak
Opp 1
Risk 5

Thesis: Risk is moderate because the only described usable context says the company was looking to secure its future, while all dated evidence shown is outside the allowed recent evidence window, leaving the current business state uncertain.

Why now: The only surfaced article is dated February 17, 2026, outside the reviewed sources cutoff date of March 29, 2026, and the evidence recent evidence review says both rows were dropped; the article summary said Orbex released new photographs of its microlauncher Prime 'as the company looks to secure a future'. Because this is outside recent evidence window, recency support is absent.

Evidence
  • Article summary said Orbex released photographs of Prime as the company looks to secure a future, but it is dated February 17, 2026 and was dropped by the 90-day recent evidence window. space.n2k.com

Caveats: Primary surfaced evidence is outside recent evidence window and should not be treated as current proof. No in-recent evidence window direct positive or negative evidence is available.

10
Orbital Inc.
mediummedium
Opp 6
Risk 5

Thesis: Risk is moderate because the reviewed sources provide only supporting article context and no direct evidence of contracts, deployment milestones, customer traction, or technical validation beyond the funding/context claim.

Why now: The usable evidence is recent within the 90-day recent evidence window: an April 14, 2026 article said Orbital got funded by Andreessen Horowitz to verify its space-based data center concept, which is relevant to a 1 year+ horizon because financing can support technology proof and strategic positioning

Evidence
  • AI satellite constellation startup Orbital gets funded by a16z to verify space-based data center concept. siliconangle.com

Caveats: Evidence is supporting article context/weak context rather than direct positive events. No reviewed sources evidence of customers, revenue, launch schedule, or technical milestone completion. Same article appears in multiple weak-context rows and should not be treated as independent confirmation.

11
Quantum Space
mediummedium
Opp 8
Risk 5

Thesis: The company still carries meaningful execution and transaction risk because the SPAC deal is only expected to close in the fourth quarter rather than already complete, contract value was undisclosed, and key program delivery is pushed out to 2028, leaving room for financing, closing, and execution slippage.

Why now: The evidence is recent and sequenced: on June 8, 2026 Quantum Space announced its planned SPAC merger and expected Nasdaq listing under QSPC

Evidence
  • Published June 8, 2026: the SPAC merger is expected to close in the fourth quarter, implying completion risk remains; access to the full trust depends on shareholder redemptions. spacenews.com
  • Published June 18, 2026: contract value was not disclosed and the company expects to deliver the vehicle by 2028, creating long-dated execution risk. spacenews.com
  • Published June 8, 2026: Quantum Space announced it will merge with Inflection Point Acquisition Corp. VI, expects the deal to close in the fourth quarter, and says the deal includes a $300 million PIPE plus $253 million in SPAC trust assuming no redemptions. spacenews.com

Caveats: Most available evidence is external overlay context rather than first-party positive or negative events. Same-theme repetition across June articles is not independent confirmation. Ticker QSPC is prospective after the expected SPAC close per June 8, 2026 evidence, not confirmed as already trading under that symbol

12
Sateliot
mediummedium
Opp 7
Risk 5

Thesis: Risk remains material because later evidence indicates the Series C is being sought rather than fully closed and that Sateliot is still seeking a lead investor, with up to 50% public co-financing hoped to match private investment. That means financing completion and constellation deployment remain execution-sensitive.

Why now: The sequence matters: the company launched the Series C on April 8, 2026/April 13, 2026, then later reporting on May 21, 2026 noted a first commercial launch contract, and June 24, 2026 reporting still described the round as seeking capital and a lead investor. That mix creates both opportunity and financing risk over a 1 year+ horizon.

Evidence
  • Published June 24, 2026, this says Sateliot is looking to raise new equity funding, is currently seeking to attract a lead investor, and anticipates up to 50 percent public co-financing. datacenterdynamics.com
  • TelecomTV says Sateliot is seeking €100 million in Series C funding and is looking to bring in a lead investor, indicating financing is still in process. Published April 13, 2026. telecomtv.com
  • Company-linked fact says Sateliot launched a €100 million Series C round to deploy 16 satellites for 5G IoT and direct-to-device connectivity. Published April 13, 2026. computerweekly.com

Caveats: The reviewed sources does not provide a direct positive event row for the first commercial contract; that support is supporting article context and weaker than a structured company event row. Later dated coverage indicates financing is still being sought, which partially offsets the opportunity thesis. Undated context items exist in the reviewed sources but are not used for recency-sensitive judgments.

13
Spark Space
mediummedium
Opp 5
Risk 5

Thesis: Risk is equally meaningful because the evidence is undated supporting article context, so recency is uncertain and there is no direct evidence of launch contracts, orbital milestones, or sustained financing beyond the article summary.

Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously.

Evidence
  • Chinese startup developing electric-pump rocket; raised funds and tested engine. spacenews.com

Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation.

14
Turion Space
mediummedium
Opp 7
Risk 5

Thesis: Risk remains meaningful because the evidence still describes an early-stage company scaling from a small launched base into a persistent constellation and potentially adjacent on-orbit services, which implies execution and capital deployment risk; however, the reviewed sources contain no direct adverse event evidence.

Why now: The key timing driver is the dated financing round on April 15, 2026, which the reviewed sources say positions the company to scale beyond single-mission spacecraft toward a persistent SDA constellation, a development relevant over a 1 year+ horizon.

Evidence
  • Turion Space closed a $75 million Series B round on April 15, 2026, to accelerate deployment of its space domain awareness satellite fleet; total capital raised is approximately $115 million. orbital-intel.com
  • Turion Space said it has raised more than $75 million in a Series B round; it develops satellites and payloads focused on space domain awareness and had launched two spacecraft, with Droid.002 deployed in March. spacenews.com

Caveats: The reviewed sources have no direct positive or negative dated events; the case relies on supporting article context rather than stronger internal company-specific events. The company website context on May 23, 2026 is weaker than independent company-specific event evidence and should not be overweighted. Citation

15
Volta Space Technologies
lowweak
Opp 4
Risk 5

Thesis: Risk is moderate to elevated because the cited milestone is far out, execution risk is likely high, and the reviewed sources exposes no direct article summary or to confirm near-term de-risking.

Why now: The rationale cites article and says the company has a 2028 demonstration planned with payload booked on Blue Ghost Mission 2, which is relevant to a 1 year+ strategic horizon but weak for immediate evidence-based ranking because no article body or is visible.

Caveats: No visible representative article, quote, or in the reviewed sources body. The main cited demonstration is scheduled for 2028, so commercial payoff may sit beyond the stated 1 year+ ranking horizon. The Firefly payload linkage cannot be used as counterparty propagation evidence beyond the explicit rationale.

16
Albedo
lowweak
Opp 4
Risk 4

Thesis: Risk is also meaningful because this evidence is supporting article context only, not direct event/fact evidence in the reviewed sources' stronger fields, and the article describes Albedo as a former Earth-observation startup now focused on satellite manufacturing, implying strategic transition/execution uncertainty

Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission

Evidence
  • Representative article summary: Albedo announced plans April 9 to send its second spacecraft; summary says the company prepares a second VLEO mission for 2027 launch. spacenews.com

Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation.

17
Apex Space
mediummedium
Opp 8
Risk 4

Thesis: Risk is moderate, not because of explicit adverse evidence, but because the strongest structured support is neutral fact/context rather than explicit positive events in the reviewed sources. The evidence leans heavily on company/external article context and financing narratives, so execution risk around scaling manufacturing and converting strategic positioning into durable contracts remains an offset.

Why now: Why now is strong because the key financing evidence is dated June 5, 2026 and the Northrop partnership article is dated June 1, 2026, making both recent within the 90-day recent evidence window and relevant to a 1 year+ scaling thesis. The June 5 financing event is later than the April 16 capacity/context article and therefore better reflects current business state.

Evidence
  • Apex raised over $200 million at a $2.3 billion valuation to scale satellite bus production for proliferated constellations. Published June 5, 2026. apexspace.com
  • Corroborating dated fact: Apex raised over $200 million at a $2.3 billion valuation to scale satellite bus production for proliferated constellations. Published June 5, 2026. payloadspace.com
  • Article says Northrop Grumman partnered with Apex to develop space-based interceptors for the Golden Dome missile defense program; June 1, 2026. spacenews.com

Caveats: Most available evidence is neutral fact or supporting article context, not explicit positive events. Same-day repeated articles around the fundraise are not independent proof beyond corroboration. Some context sources are company-issued or article-level summaries, which are weaker than direct events.

18
Astrobase Space Technologies
mediummedium
Opp 6
Risk 4

Thesis: Risk remains material because the visible evidence is supporting article context around funding and ambition rather than proof of technical milestone completion, customer adoption, or flight success. Deep-tech engine development inherently depends on execution, but the reviewed sources does not document adverse events.

Why now: The funding article is recent, with published June 12, 2026, and specifically notes this as IN-SPACe's first investment in Indian startups under the TAF scheme. That timing matters for a 1 year+ horizon because it may enable development progress over coming quarters.

Evidence
  • Published June 12, 2026: IN-SPACe selected Astrobase Space Technologies under its Technology Adoption Fund; selected startups 'will each receive a maximum of ₹25 crore' and Astrobase aims to develop a 'high-thrust closed-cycle liquid rocket engine.' startup.economictimes.indiatimes.com

Caveats: Visible evidence is only one external article summary despite the membership rationale referencing multiple structured support articles. No technical test results or customer contracts are provided in the exposed evidence.

19
Astroscale
mediummedium
Opp 7
Risk 4

Thesis: The reviewed sources also indicates Astroscale is still transitioning from technology demonstrations into repeatable commercial work, and its May 2026 financing cites an uncertain market environment, so scaling and capital-market dependence remain meaningful risks.

Why now: Recency is the main reason: on June 22, 2026 SpaceNews said Astroscale was 'working to transition from technology demonstrations to a regular series of missions, bolstered by a recent capital infusion' and saw 'repeatable business opportunities' particularly among defense customers. On May 19, 2026 financing materials said the company would raise 30.6 billion yen to secure medium-to-long-term growth funding 'in anticipation of transitioning to a phase of continuous order acquisition'. On April 6, 2026 Astroscale revealed its ISSA-J1 mission scheduled for launch in 2027.

Evidence
  • Published June 22, 2026: the company is still transitioning from demonstration missions to regular commercial missions, implying execution risk before repeatability is proven. spacenews.com
  • Published May 19, 2026: financing materials reference raising capital amid an 'uncertain market environment,' indicating ongoing funding and market-condition sensitivity. finance.biggo.com
  • Published June 22, 2026: Astroscale is 'working to transition from technology demonstrations to a regular series of missions, bolstered by a recent capital infusion' with prospects for 'repeatable business opportunities,' particularly among defense customers. spacenews.com

Caveats: Most within the recent evidence window evidence is supporting article context, not structured company-specific events; reviewed sources warns supporting article context is weaker than direct event/fact evidence. Same-article repeated weak-context rows are not independent confirmation. Older 2023 and 2025 articles exist in representative articles but fall outside the 90-day recent evidence window for ranking use.

20
BlackSky Technology Inc.
highstrong
Opp 8
Risk 4

Thesis: Risk is still moderate because the $99 million item is an IDIQ ceiling with only initial funding disclosed, and much of the reviewed sources support is article-context level rather than dated events; execution on next-generation payload design and constellation roadmap still matters.

Why now: The why-now is supported by two dated recent wins inside the recent evidence window: on March 31, 2026 BlackSky said it received a multi-year sole-source $99 million U.S. government IDIQ and initial $2 million funding for advanced large-aperture payload design; on April 22, 2026 it announced a competitive $25 million multi-year assured contract with a major international defense customer and said it had four Gen-3 satellites on orbit and was rapidly deploying Gen-3 capacity while driving up backlog and annual recurring revenue.

Evidence
  • BlackSky was awarded a multi-year, sole-source $99 million U.S. government IDIQ contract and received an initial $2 million to accelerate design of an advanced large aperture optical payload for Earth observation and space domain awareness platforms. businesswire.com
  • BlackSky won a competitive $25 million, multi-year Assured contract with a major international defense customer; the company said four Gen-3 satellites are on orbit and it is rapidly deploying Gen-3 capacity while driving up backlog and annual recurring revenue. ir.blacksky.com

Caveats: The $99 million figure is an IDIQ ceiling, not fully funded revenue at announcement; only an initial $2 million was specifically disclosed. Some corroboration repeats the same underlying announcement and should not be treated as independent evidence